Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Implementation of a Novel Functional Eye-Tracking Biomarker for Multiple Sclerosis

NCT05277740 is registered in ClinicalTrials.gov with McGill University as lead sponsor.

NCT NCT05277740
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05277740 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Implementation of a Novel Functional Eye-Tracking Biomarker for Multiple Sclerosis
Lead sponsor
McGill University
Phase
Observational
Overall status
Unknown status
Start date
September 1, 2022
Completion date
July 31, 2024
Enrollment
120 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

clinically isolated syndrome, relapsing remitting multiple sclerosis